ValueClick shares drop 22% on Q2 outlook
Shares of online advertising firm ValueClick plunged 22.2 percent after the Westlake Village-based firm projected lower-than-expected second-quarter revenues of between $155 million and $160 million. One analyst told Bloomberg News that the company is reducing traffic in its owned-and-operated website segment. ValueClick reported first-quarter profits of $21.6 million – 27.8 percent above the same quarter Read More →
Read More →Ventura startup aims to make real estate sales a social business
Ventura Home Team wants to put a socially responsible spin on real estate selling.
Read More →Amgen to buy Turkish firm in $700M deal
Thousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
Read More →Teledyne’s profits rise in Q1
Thousand Oaks-based Teledyne Technologies beat Wall Street’s expectations on April 25 when it reported first-quarter profits of $35.7 million on $494 million in sales. The profits work out to 96 cents a share, well above the 91-cent average estimate of six analysts, according to data from Thomson Reuters. Sales were 5.5 percent above the same Read More →
Read More →Amgen’s founding CEO dies
George Rathmann, the founding CEO of Thousand Oaks-based Amgen, has died, the company said April 23. Born in 1927, Rathmann helmed what is now Ventura County’s largest private-sector employer from 1980 to 1988 and was the chairman of the board until 1990. He had been recruited by Bill Bowes, one of Amgen’s founders, to run Read More →
Read More →